Evolutionary Action Score Identifies a Subset of TP53 Mutated Myelodysplastic Syndrome with Favorable Prognosis, Rashmi Kanagal-Shamanna, Guillermo Bravo, Panagiotis Katsonis, Koji Sasaki, Caleb Class, Christopher Benton, Elias Jabbour, Kelly Chien, Rajyalakshmi Luthra, Carlos Bueso-Ramos, Tapan Kadia, Michael Andreeff, Nicholas Short, Naval Daver, Mark Routbort, Joseph Khoury, Keyur Patel, Irene Ganan-Gomez, Yue Wei, Gautam Borthakur, Farhad Ravandi, Kim-Anh Do, Kelly Soltysiak, Olivier Lichtarge, L. Medeiros, Hagop Kantarjian, Guillermo Garcia-Manero
Scholarship and Professional Work – COPHS

Loss of EZH2 Protein Expression in Myelodysplastic Syndrome Correlates with EZH2 Mutation and Portends a Worse Outcome, Ali Sakhdari, Caleb Class, Guillermo Montalban-Bravo, Koji Sasaki, Carlos Bueso-Ramos, Keyur Patel, Joseph Khoury, Hagop Kantarjian, Guillermo Garcia-Manero, L. Medeiros, Rashmi Kanagal-Shamanna
Scholarship and Professional Work – COPHS

Evolutionary Action (EA) Score of TP53 Mutations Defines Prognostic Subsets within TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia, Rashmi Kanagal-Shamanna, Guillermo Montalban-Bravo, Caleb Class, Koji Sasaki, Christopher Benton, Kelly Soltysiak, Elias Jabbour, Tapan Kadia, Carlos Bueso-Ramos, Keyur Patel, Mark Routbort, Irene Ganan-Gomez, Yue Wei, Gautam Borthakur, Farhad Ravandi, Kim-Anh Do, L. Medeiros, Hagop Kantarjian, Guillermo Garcia-Manero
Scholarship and Professional Work – COPHS